$IPSC
Century Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is IPSC up today? It is at $2.13 (+5.45%), and our scanner flagged it 13 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment IPSC spikes, and full due diligence on IPSC — key stats, earnings, dilution and insider activity. Free.
Get free $IPSC alerts the moment volume spikes
Our scanner flagged $IPSC 13 times in the last 30 days. Create a free account to track $IPSC, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $2.13
- Change today
- +5.45%
- Previous close
- $2.02
- 52-week range
- $0.435 – $3.04
- Market cap
- $375M
- Total held
- 2.4%
- Tradeable float
- 176.7M 98% of shares · after 2% insiders + institutional n/a
- Short interest
- 29.8M ▲ +5% vs prior · as of 2026-07-31
- Short % of float
- 16.9%
- Days to cover
- 40.7d
- Avg daily volume
- 1.3M
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- XNAS
- 5mthin
- 200x
- 15mthin
- 200x
- 1hthin
- 200x
- 1D
- --
Get free IPSC + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $IPSC up today?
Here is the latest on IPSC from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for IPSC today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystCentury Therapeutics Reports Second Quarter 2026 FinancialReported Cash runway into 1Q 2029 with cash, cash equivalents, and investments of $197.2 million as of June 30, 2026Reported Cash Position: Cash, cash equivalents, and investments were $197.2 million as of June 30, 2026, as compared to $117.1Reported Research and Development (R&D) Expenses: R&D expenses were $19.6 million for the quarter ended June 30, 2026,, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Aug 18, 2026 · 5 days agoInsiders
Insiders selling0 buys, 9 sells last 3 months (8/31 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Pfeiffenberger Brent Officer | Sold (automatic/other) | -31K 0.02% of company | sold 0.9% | 3.63M | $60K at $1.92 | Aug 14, 26 |
Carr Douglas Officer | Sold (automatic/other) | -275 | sold <0.1% | 505K | $545 at $1.98 | Aug 3, 26 |
Carr Douglas Officer | Sold (automatic/other) | -2K | sold 0.3% | 505K | $4K at $2.23 | Jun 12, 26 |
Russotti Gregory Officer | Sold (automatic/other) | -3K | sold 0.5% | 512K | $6K at $2.23 | Jun 12, 26 |
Cowan Chad Officer | Sold (automatic/other) | -358 | sold <0.1% | 1.18M | $802 at $2.24 | Jun 11, 26 |
Pfeiffenberger Brent Officer | Sold (automatic/other) | -14K | sold 0.4% | 3.67M | $31K at $2.24 | Jun 11, 26 |
Carr Douglas Officer | Sold (automatic/other) | -249 | sold <0.1% | 507K | $525 at $2.11 | Jun 8, 26 |
Russotti Gregory Officer | Sold (automatic/other) | -524 | sold 0.1% | 515K | $1K at $2.11 | Jun 8, 26 |
Pfeiffenberger Brent Officer | Sold (automatic/other) | -463 | sold <0.1% | 3.68M | $986 at $2.13 | Jun 5, 26 |
Pfeiffenberger Brent Officer | Sold (automatic/other) | -31K 0.02% of company | sold 0.8% | 3.68M | $73K at $2.34 | May 15, 26 |
Carr Douglas Officer | Sold (automatic/other) | -264 | sold <0.1% | 507K | $618 at $2.34 | May 4, 26 |
Cowan Chad Officer | Sold (automatic/other) | -1K | sold 0.1% | 1.18M | $3K at $2.19 | Apr 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Active shelfRecent share offering + active shelf on file — the company raised capital and can raise more. If $IPSC runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 506,915,533 new shares
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$IPSC Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$IPSC Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to IPSC
Comparable names in biological products, (no diagnostic substances), closest in size first.
IPSC stock FAQ
Why is $IPSC up today?
Here is the latest on IPSC from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for IPSC today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the IPSC stock price today?
IPSC last traded at $2.13, up 5.45% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live IPSC alerts?
The IPSC Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged IPSC 13 times in the last 30 days.
What exchange is IPSC on?
IPSC (Century Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $375M in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Is IPSC good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge IPSC for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.